Pfizer missed a deadline to turn over internal studies on myocarditis, per an FDA order. The deadline came and went. Now, they quietly have a new date in June. Why the delay on such important data? And, why does the FDA set arbitrary deadlines which aren’t enforced?
#VRBPAC #Myocarditis #Deadline #FDA #Pfizer
Published on 2 years, 10 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate